Dr. Lada Rasochova is the executive director of the California Institute for Innovation and Development, managing director of the Rady Venture Fund and director of StartR accelerator at the Rady School of Management at the University of California San Diego. Dr. Rasochova has been involved in commercialization of pharmaceutical and biotechnology products for the past 20 years. She spent more than 15 years in industry where she held various leadership positions, most recently as the leader of vaccine technologies and director of new business development in the Dowpharma division of the Dow Chemical Company. Prior to Dow, she was with Mycogen, a San Diego biotechnology startup that was acquired by Dow Chemical in 1998. After joining the University of California, San Diego in 2008, Dr. Rasochova co-founded the California Institute for Innovation that serves as a hub for innovation, entrepreneurial education and technology commercialization at Rady. She also co-founded the Rady Venture Fund, a venture capital fund at the UC San Diego that invests in early stage technology ventures and StartR accelerator that provides support to emerging startup companies. Rasochova teaches graduate level courses in Technology Commercialization and Venture Capital Management and serves on boards of several startup companies. Dr. Rasochova is a virologist and biochemist by training; she received her Ph.D. in molecular, cellular, and developmental biology from Iowa State University and MBA from the Rady School of Management at UC San Diego. She is an inventor on several patents.
Kim Davis King
Kimberly Davis King co-leads the StartR incubator with Lada.Rasochova. She has over 17 years in the venture capital industry. Kim has been focused on investing and mentoring startups and high growth companies. Kim is also currently a lecturer at the Rady UC San Diego Business School, an adjunct professor at SDSU, on the oversight committee for Evonexus a San Diego incubator and heads business development for Cashie Commerce. Kim is an advisor to several early stage and growth companies including Cashie Commerce, Reel Qualified, Cypher Genomics, Embarke, ZafeSoft, Pathway Genomics, PhiloMetron and Verve Wireless. In 2007, Kim relocated to San Diego and opened the office for Hercules Technology Growth Capital. Before joining Hercules, Kimwas a General Partner with IDG Ventures from 1997 to 2006. She played an active role in managing and investing over 9 years a $120 million captive fund. She led multiple investments in software and technology infrastructure. Successful IPO investments included F5 Networks (FFIV), ServicMetrics (Exodus) and VA Linux (LINUX). Prior to joining IDG Ventures, she was anAssociate at BankAmerica Ventures. She has also served as a product manager in the Multimedia Publishing Group at Microsoft and spent four years as a consultant at Andersen Consulting. Kim holds a B.S in Industrial Engineering from Stanford University and a M.B.A. from the Harvard Business School. She sits on various non-profit boards and holds leadership positions including the UC San Diego StartupXX, UC San Diego Rady StartR, RSF Unit Children's Hospital, Commnexus/EvoNexus, HBS Alumni Board, RSF Education Foundation, and the RSF Foundation.